0001388295 2026-01-01 2026-06-30 0001388295 2026-08-14 0001388295 2026-06-30 0001388295 2025-12-31 0001388295 us-gaap:NonrelatedPartyMember 2026-06-30 0001388295 us-gaap:NonrelatedPartyMember 2025-12-31 0001388295 us-gaap:RelatedPartyMember 2026-06-30 0001388295 us-gaap:RelatedPartyMember 2025-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2026-06-30 0001388295 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember 2025-12-31 0001388295 2025-01-01 2025-06-30 0001388295 2026-04-01 2026-06-30 0001388295 2025-04-01 2025-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001388295 us-gaap:CommonStockMember 2025-12-31 0001388295 ONEI:CommonStockLiabilityMember 2025-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001388295 us-gaap:RetainedEarningsMember 2025-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001388295 us-gaap:CommonStockMember 2026-03-31 0001388295 ONEI:CommonStockLiabilityMember 2026-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001388295 us-gaap:RetainedEarningsMember 2026-03-31 0001388295 2026-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001388295 us-gaap:CommonStockMember 2024-12-31 0001388295 ONEI:CommonStockLiabilityMember 2024-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2024-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001388295 us-gaap:RetainedEarningsMember 2024-12-31 0001388295 2024-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001388295 us-gaap:CommonStockMember 2025-03-31 0001388295 ONEI:CommonStockLiabilityMember 2025-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001388295 us-gaap:RetainedEarningsMember 2025-03-31 0001388295 2025-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001388295 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001388295 ONEI:CommonStockLiabilityMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-01-01 2026-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001388295 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001388295 2026-01-01 2026-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001388295 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001388295 ONEI:CommonStockLiabilityMember 2026-04-01 2026-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-04-01 2026-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001388295 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001388295 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001388295 ONEI:CommonStockLiabilityMember 2025-01-01 2025-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-01-01 2025-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001388295 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001388295 2025-01-01 2025-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001388295 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001388295 ONEI:CommonStockLiabilityMember 2025-04-01 2025-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-04-01 2025-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001388295 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001388295 us-gaap:CommonStockMember 2026-06-30 0001388295 ONEI:CommonStockLiabilityMember 2026-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001388295 us-gaap:RetainedEarningsMember 2026-06-30 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001388295 us-gaap:CommonStockMember 2025-06-30 0001388295 ONEI:CommonStockLiabilityMember 2025-06-30 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-06-30 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001388295 us-gaap:RetainedEarningsMember 2025-06-30 0001388295 2025-06-30 0001388295 ONEI:OEMAgreementMember 2024-10-08 0001388295 ONEI:OEMAgreementMember 2025-01-01 2025-12-31 0001388295 ONEI:OEMAgreementMember 2026-04-01 2026-06-30 0001388295 ONEI:OEMAgreementMember 2026-01-01 2026-06-30 0001388295 ONEI:OEMAgreementMember 2026-06-30 0001388295 ONEI:MasterResellerAgreementMember 2026-04-08 0001388295 ONEI:MasterResellerAgreementMember 2026-06-30 0001388295 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-01-01 2026-06-30 0001388295 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-06-30 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-06-30 0001388295 ONEI:SubscriptionLicenseAndSoftwareRevenueMember 2026-01-01 2026-06-30 0001388295 ONEI:SubscriptionLicenseAndSoftwareRevenueMember 2025-01-01 2025-06-30 0001388295 ONEI:ProfessionalServicesMember 2026-01-01 2026-06-30 0001388295 ONEI:ProfessionalServicesMember 2025-01-01 2025-06-30 0001388295 ONEI:OEMSolutionMember 2026-01-01 2026-06-30 0001388295 ONEI:OEMSolutionMember 2025-01-01 2025-06-30 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2026-01-01 2026-06-30 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2025-01-01 2025-06-30 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2026-06-30 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2025-12-31 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2026-01-01 2026-06-30 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2025-01-01 2025-06-30 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2026-06-30 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2025-12-31 0001388295 srt:ChiefExecutiveOfficerMember 2026-06-30 0001388295 srt:ChiefExecutiveOfficerMember 2026-02-02 2026-02-02 0001388295 srt:ChiefExecutiveOfficerMember 2026-02-02 0001388295 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-06-30 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-01-27 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-02-01 2026-02-01 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-06-30 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2025-01-01 2025-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-01-01 2024-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2025-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2026-06-30 0001388295 ONEI:RowlandDayMember 2025-10-31 2025-10-31 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 srt:MinimumMember ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 srt:MaximumMember ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 srt:MinimumMember ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 srt:MaximumMember ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 ONEI:RowlandDayMember 2026-03-26 2026-03-26 0001388295 ONEI:RowlandDayMember 2026-03-27 0001388295 ONEI:RowlandDayMember 2026-03-26 0001388295 ONEI:StockRepurchaseAgreementMember 2026-04-10 2026-04-10 0001388295 ONEI:StockRepurchaseAgreementMember 2026-04-10 0001388295 ONEI:RowlandDayMember 2026-06-30 0001388295 ONEI:RowlandDayMember 2026-04-10 2026-04-10 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember 2025-12-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001388295 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-12-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-06-30 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 2025-12-25 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2024-12-01 2024-12-31 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-12-31 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-06-30 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-06-30 0001388295 us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 ONEI:PurchaseAgreementsMember 2025-10-31 0001388295 srt:MaximumMember ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 srt:MinimumMember ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 0001388295 ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 2026-02-11 0001388295 ONEI:ThreeMonthsThereafterMember ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 2026-02-11 0001388295 ONEI:PromissoryNoteOneMember 2025-09-11 2025-09-11 0001388295 ONEI:PromissoryNoteOneMember 2025-09-11 0001388295 ONEI:PromissoryNoteOneMember 2026-01-01 2026-06-30 0001388295 ONEI:PromissoryNoteOneMember 2026-06-30 0001388295 ONEI:PromissoryNoteOneMember 2025-12-31 0001388295 ONEI:PromissoryNoteOneMember us-gaap:RelatedPartyMember 2026-06-30 0001388295 ONEI:PromissoryNoteOneMember us-gaap:RelatedPartyMember 2025-12-31 0001388295 2025-10-13 2025-10-13 0001388295 ONEI:PromissoryNoteTwoMember 2025-10-13 2025-10-13 0001388295 ONEI:PromissoryNoteTwoMember 2025-10-13 0001388295 ONEI:PromissoryNoteTwoMember 2026-01-01 2026-06-30 0001388295 ONEI:PromissoryNoteTwoMember 2026-06-30 0001388295 ONEI:PromissoryNoteTwoMember 2025-12-31 0001388295 ONEI:PromissoryNoteTwoMember us-gaap:RelatedPartyMember 2026-06-30 0001388295 ONEI:PromissoryNoteTwoMember us-gaap:RelatedPartyMember 2025-12-31 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-03-26 0001388295 ONEI:PromissoryNoteThreeMember 2026-01-01 2026-06-30 0001388295 ONEI:PromissoryNoteThreeMember 2026-06-30 0001388295 ONEI:PromissoryNoteThreeMember us-gaap:RelatedPartyMember 2026-06-30 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-05-13 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-05-13 2026-05-13 0001388295 ONEI:TwoInvestorsMember ONEI:PromissoryNoteFourMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-01-01 2026-06-30 0001388295 ONEI:TwoInvestorsMember ONEI:PromissoryNoteFourMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-06-30 0001388295 ONEI:PromissoryNoteFourMember 2026-06-30 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-05-28 0001388295 2026-05-28 2026-05-28 0001388295 2026-05-28 0001388295 ONEI:PromissoryNoteFiveMember 2026-01-01 2026-06-30 0001388295 ONEI:PromissoryNoteFiveMember 2026-06-30 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-06-12 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-06-12 2026-06-12 0001388295 ONEI:TwoInvestorsMember ONEI:PromissoryNoteSixMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-01-01 2026-06-30 0001388295 ONEI:TwoInvestorsMember ONEI:PromissoryNoteSixMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-06-30 0001388295 ONEI:PromissoryNoteSixMember 2026-06-30 0001388295 ONEI:PromissoryNoteMember 2026-06-30 0001388295 ONEI:PromissoryNoteMember 2025-12-31 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2026-06-30 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2026-01-01 2026-06-30 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-01-01 2026-06-30 0001388295 ONEI:SeriesBOnePreferredStockMember 2023-09-30 2023-09-30 0001388295 ONEI:StockRepurchaseAgreementMember 2026-01-01 2026-06-30 0001388295 ONEI:RowlandDayMember 2026-04-10 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2026-04-10 2026-04-10 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SeriesBOnePreferredStockMember 2026-03-09 2026-03-09 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-03-09 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-03-09 2026-03-09 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-04-01 2026-06-30 0001388295 ONEI:SeriesBTwoPreferredStockMember 2026-06-30 0001388295 ONEI:SeriesBTwoPreferredStockMember 2025-12-31 0001388295 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001388295 us-gaap:WarrantMember ONEI:StockPurchaseAgreementMember 2026-01-01 2026-06-30 0001388295 ONEI:ConvertiblePromissoryNotesMember 2026-01-01 2026-06-30 0001388295 ONEI:ConvertiblePromissoryNotesMember 2026-06-30 0001388295 ONEI:AccountsPayableSettlementMember 2026-01-01 2026-06-30 0001388295 ONEI:AccountsPayableSettlementMember 2026-06-30 0001388295 ONEI:ConsultantMember 2026-01-01 2026-06-30 0001388295 ONEI:ConsultantAgreementOneMember 2026-01-01 2026-01-01 0001388295 ONEI:ConsultantAgreementOneMember 2026-01-01 2026-06-30 0001388295 ONEI:SixMonthTermConsultantAgreementMember 2025-12-18 2025-12-18 0001388295 ONEI:SixMonthTermConsultantAgreementMember 2026-01-01 2026-06-30 0001388295 ONEI:ConsultantAgreementTwoMember 2025-08-01 2025-08-01 0001388295 ONEI:ConsultantAgreementTwoMember 2025-12-15 2025-12-15 0001388295 ONEI:ConsultantAgreementTwoMember 2025-01-01 2025-12-31 0001388295 ONEI:ConsultantAgreementTwoMember 2026-01-01 2026-06-30 0001388295 ONEI:ConsultantAgreementThreeMember 2025-08-01 2025-08-01 0001388295 ONEI:ConsultantAgreementThreeMember 2025-01-01 2025-12-31 0001388295 ONEI:ConsultantAgreementThreeMember 2026-01-01 2026-06-30 0001388295 ONEI:SeveralConsultantAgreementsMember 2026-06-30 0001388295 ONEI:AdvisorOneMember 2026-06-01 2026-06-01 0001388295 ONEI:AdvisorOneMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001388295 ONEI:AdvisorTwoMember 2026-03-30 2026-03-30 0001388295 ONEI:AdvisorThreeMember 2026-03-01 2026-03-01 0001388295 ONEI:AdvisorFourMember 2025-12-01 2025-12-01 0001388295 us-gaap:RestrictedStockMember 2026-06-30 0001388295 us-gaap:RestrictedStockMember 2026-01-01 2026-06-30 0001388295 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001388295 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001388295 srt:MinimumMember us-gaap:WarrantMember 2026-01-01 2026-03-31 0001388295 srt:MaximumMember us-gaap:WarrantMember 2026-01-01 2026-06-30 0001388295 us-gaap:CommonStockMember ONEI:StockPurchaseAgreementMember 2026-01-01 2026-06-30 0001388295 ONEI:TwoInvestorsMember us-gaap:WarrantMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-05-13 0001388295 us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001388295 us-gaap:MeasurementInputExercisePriceMember 2026-06-30 0001388295 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001388295 us-gaap:WarrantMember 2026-06-30 0001388295 ONEI:EmployeesMember us-gaap:EmployeeStockOptionMember 2026-02-23 2026-02-23 0001388295 us-gaap:EmployeeStockOptionMember 2026-04-01 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember 2026-06-30 0001388295 us-gaap:RestrictedStockMember 2025-12-31 0001388295 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2026-06-30 0001388295 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2026-06-30 0001388295 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2026-06-30 0001388295 us-gaap:WarrantMember 2025-12-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputSharePriceMember 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001388295 us-gaap:EmployeeStockOptionMember 2025-12-31 0001388295 ONEI:ChiefExecutiveOfficerAndDirectorMember 2024-12-31 0001388295 ONEI:TwoInvestorsMember us-gaap:SubsequentEventMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-07-14 0001388295 ONEI:TwoInvestorsMember us-gaap:SubsequentEventMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-07-14 2026-07-14 iso4217:USD shares iso4217:USD shares pure ONEI:Segment false --12-31 Q2 0001388295

10-Q true 2026-06-30 2026 false 000-56565 ONEMETA INC. NV 20-5150818 450 South 400 East Suite 200 Bountiful UT 84010 (702) 550-0122 None. Yes Yes Non-accelerated Filer true true false false 38890943

49491

4584

105127

22508

20812

94845

175430

121937

1517

1843

1517

1843

176947

123780

1104169

926889

537483

133845

124577

97000

124577

97000

19000

3140000

940000

450000

250000

450000

250000

475821 380321

514038

316196

6365088

3044251

1387612

6365088

4431863

0.001

50000000

0.001

2068

0.001

5252753

8619420

5252

862

5252

862

0.001

500000000

38890943

38891

1744812

527889

40955683

38480044

-48932781

-43355771

-6188141

-4308083

176947

123780

619483

829273

439366

700755

203361

91675

137801

91675

416122

737598

301565

609080

772413

472484

366102

122898

2625188

1144427

687435

663107

8765

16488

6754

7763

318987

413200

164620

194780

3725353

2046599

1224911

988548

-3309231

-1309001

-923346

-379468

-5304

2267779

112679

1341406

87997

-2267779

-112679

-1346710

-87997

-5577010

-1421680

-2270056

-467465

-0.14

-0.04

-0.06

-0.01

-0.14

-0.04

-0.06

-0.01

38890943

38332054

38890943

38873165

38890943

38332054

38890943

38873165

2068

8619420

862

38890943

38891

527889

38480044

-43355771

-4308083

950000 950000 1129920 1129920 946716 946716

130557

30723

252834

-3306954

2068

8619420

862

38890943

38891

1474605

1129920

37944158

-46662725

-6074287

-7757 7757 -4166667 4167 1895833 1900000 800000 -800 1129920 -1172160 -43040 270207 270207

138934

31413

166691

817604

2588313 2588313

-2270056

2068

5252753

5252

38890943

38891

1744812

40955683

-48932781

-6188141

2068

8619420

862

37790943

37791

36792679

-39516154

-2684820

83901

-954215

2068

8619420

862

37790943

37791

36876580

-40470369

-3555134

2068

8619420

862

37790943

37791

36876580

-40470369

-3555134

1000000

1000

474000

475000

100000

100

22900

23000

66429

83901

-467465

2068

8619420

862

38890943

38891

37523810

-40937834

-3374269

2068

8619420

862

38890943

38891

37523810

-40937834

-3374269

-5577010

-1421680

1023113

326

62136 66429

1442451

190802

817604 1216923

82619

66229

-74033

-82049

197364

306167

403638

47381

7493 -14696

2786155

-180000

2371607

-989777

420000

1015700

200000

190000

200000

250000

80000 45500 80000 145500

25000

6000

2150000

475000

-2326700

815000

44907

-174777

4584

215816

49491

41039

156164

20084 195118 700000 419525 7757 2588313

Note 1. Basis of Presentation The accompanying unaudited interim financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the financial statements and notes thereto contained in the Company’s fiscal 2025 financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the financial statements for fiscal 2025, have been omitted. OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Note 2. Summary of Significant Accounting Policies Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts. Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less. Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of June 30, 2026 and December 31, 2025, there was $1,160 of allowance for credit losses. Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions. Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates. Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> Subscription and license We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. OEM solution The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups. The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution. VerbumAgentis During the period ended June 30, 2026, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company provided the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller paid an initial one-time paid-up fee of $500,000. VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction. VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260101__20260630_zofzsO96ldqe" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250630_zb74lSofJ71a" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_z9yjCEL3XBjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">502,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zxNgTyd4Jw7b" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">590,878</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">326,460</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_z2pZT4rmMmYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,350</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">313</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z5KTxpgRckyc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">619,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">829,273</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company estimated the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. During the three months ended June 30, 2026, the Company recognized $125,236 as revenue from the credit. During the six months ended June 30, 2026, the Company recognized $235,932 as revenue from the credit. As of June 30, 2026, the deferred revenue balance was $15,263, which the Company expects to recognize revenue in the following quarter. On April 8, 2026, the Company entered into a Master Reseller Agreement (the “Reseller Agreement”) for an initial term of three-years with Avaya LLC (“Avaya”). Upon execution of the agreement, the Company received $3,000,000 as a credit balance for future service. Under the Reseller Agreement, Avaya is authorized to resell the Company’s cloud-based software-as-a-service (SaaS) offerings and related professional and support services (collectively, the “Services”) to its customers and distributors worldwide. The Services include real-time and batch translation, transcription, captioning, interpretation, and related AI-powered language services, as well as professional services such as implementation, configuration, integration, training, and technical support. The Company’s performance obligations include providing access to SaaS offerings (translation, transcription, etc.) and delivering professional services (implementation, training, support). Transaction price is determined based on the contractual rates for each service, as set forth in the Reseller Agreement. Revenue for SaaS services is recognized over time as the customer consumes the services (e.g., per minute of translation or transcription), as the customer simultaneously receives and consumes the benefits of the services. Revenue for professional services is recognized over time as the services are performed. The Company acts as principal in providing the services to the customer, as it controls the services before they are transferred to the end customer. In connection with the Reseller Agreement, the Company granted the issuance of a 10ten-year warrant to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYWcMVW31gfc" title="Warrant to purchase of common stock, shares">22,222,222 shares of common stock with exercise price of $0.135. The warrant had a fair value of $2,588,313, which was recorded as a discount against the $3,000,000 pre-payment received from the customer. As of June 30, 2026, the deferred revenue from the Reseller agreement was $343,775. Included in total deferred revenue are other deferred customer contracts amounting to $155,000 and $65,000 as of 6/30/2026 and 12/31/2025, respectively. As of June 30, 2026 and December 31, 2025, the deferred revenue balance was $514,038 and $316,196, respectively. Stock-Based Compensation All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date. Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2026, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zrgxI68s8ykl" title="Warrants outstanding">41,252,678 common shares, options to purchase <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zc6Uag3BnqY" title="Options outstanding">4,815,000 common shares, conversion of Series B-1 shares to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBOnePreferredStockMember_zF8cU5CIjDx" title="Conversion shares">57,780,283 common shares, conversion of Series A shares to purchase <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesAPreferredStockMember_zwWR49qgnxeb" title="Conversion shares">2,585 common shares, and the conversion of the convertible notes to <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_z9nXCxZCuvSi" title="Conversion shares">36,045,673 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations as of June 30, 2026 and 2025, reflected in the accompanying statement of operations. Segments Reporting The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment. Recent Accounting Pronouncements Disaggregation of Income Statement Expenses In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures. Credit Losses In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. We adopted ASU No. 2025-05 during the year ended December 31, 2026, with no material impact to the Company’s financial statements or results of operations.

Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts.

Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of June 30, 2026 and December 31, 2025, there was $1,160 of allowance for credit losses.

1160

Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> Subscription and license We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. OEM solution The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups. The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution. VerbumAgentis During the period ended June 30, 2026, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company provided the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller paid an initial one-time paid-up fee of $500,000. VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction. VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260101__20260630_zofzsO96ldqe" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250630_zb74lSofJ71a" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_z9yjCEL3XBjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">502,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zxNgTyd4Jw7b" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">590,878</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">326,460</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_z2pZT4rmMmYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,350</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">313</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z5KTxpgRckyc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">619,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">829,273</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company estimated the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. During the three months ended June 30, 2026, the Company recognized $125,236 as revenue from the credit. During the six months ended June 30, 2026, the Company recognized $235,932 as revenue from the credit. As of June 30, 2026, the deferred revenue balance was $15,263, which the Company expects to recognize revenue in the following quarter. On April 8, 2026, the Company entered into a Master Reseller Agreement (the “Reseller Agreement”) for an initial term of three-years with Avaya LLC (“Avaya”). Upon execution of the agreement, the Company received $3,000,000 as a credit balance for future service. Under the Reseller Agreement, Avaya is authorized to resell the Company’s cloud-based software-as-a-service (SaaS) offerings and related professional and support services (collectively, the “Services”) to its customers and distributors worldwide. The Services include real-time and batch translation, transcription, captioning, interpretation, and related AI-powered language services, as well as professional services such as implementation, configuration, integration, training, and technical support. The Company’s performance obligations include providing access to SaaS offerings (translation, transcription, etc.) and delivering professional services (implementation, training, support). Transaction price is determined based on the contractual rates for each service, as set forth in the Reseller Agreement. Revenue for SaaS services is recognized over time as the customer consumes the services (e.g., per minute of translation or transcription), as the customer simultaneously receives and consumes the benefits of the services. Revenue for professional services is recognized over time as the services are performed. The Company acts as principal in providing the services to the customer, as it controls the services before they are transferred to the end customer. In connection with the Reseller Agreement, the Company granted the issuance of a 10ten-year warrant to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYWcMVW31gfc" title="Warrant to purchase of common stock, shares">22,222,222 shares of common stock with exercise price of $0.135. The warrant had a fair value of $2,588,313, which was recorded as a discount against the $3,000,000 pre-payment received from the customer. As of June 30, 2026, the deferred revenue from the Reseller agreement was $343,775. Included in total deferred revenue are other deferred customer contracts amounting to $155,000 and $65,000 as of 6/30/2026 and 12/31/2025, respectively. As of June 30, 2026 and December 31, 2025, the deferred revenue balance was $514,038 and $316,196, respectively.

500000

The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260101__20260630_zofzsO96ldqe" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250630_zb74lSofJ71a" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_z9yjCEL3XBjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,255</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">502,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zxNgTyd4Jw7b" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">590,878</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">326,460</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_z2pZT4rmMmYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,350</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">313</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z5KTxpgRckyc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">619,483</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">829,273</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1255

502500

590878

326460

27350

313

619483

829273

700000

448804

125236

235932

15263

3000000

P10Y

22222222

0.135

2588313 3000000

343775

155000

65000

514038

316196

Stock-Based Compensation All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date.

Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2026, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zrgxI68s8ykl" title="Warrants outstanding">41,252,678 common shares, options to purchase <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zc6Uag3BnqY" title="Options outstanding">4,815,000 common shares, conversion of Series B-1 shares to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBOnePreferredStockMember_zF8cU5CIjDx" title="Conversion shares">57,780,283 common shares, conversion of Series A shares to purchase <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesAPreferredStockMember_zwWR49qgnxeb" title="Conversion shares">2,585 common shares, and the conversion of the convertible notes to <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_z9nXCxZCuvSi" title="Conversion shares">36,045,673 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations as of June 30, 2026 and 2025, reflected in the accompanying statement of operations.

41252678

4815000

57780283

2585

36045673

Segments Reporting The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.

Recent Accounting Pronouncements Disaggregation of Income Statement Expenses In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures. Credit Losses In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. We adopted ASU No. 2025-05 during the year ended December 31, 2026, with no material impact to the Company’s financial statements or results of operations.

Note 3. Going Concern These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of June 30, 2026, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The company has a history of prepaid revenue customers. Management is evaluating the conversion of certain outstanding debt to equity to reduce near-term cash debt-service obligations and interest expense. The Company is actively seeking funding through debt and equity offerings. Management cannot be certain that such events or a combination thereof can be achieved.

Note 4. Related Party Transactions Expense paid on the Company’s behalf During the six months ended June 30, 2026 and 2025, former chief financial officer paid $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zeezJ15wPWmk" title="Expenses paid on the company's behalf">0 and $<span id="xdx_901_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20250101__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zlVz40wcOHh2" title="Expenses paid on the company's behalf">195,118 of expenses on the Company’s behalf and was repaid $<span id="xdx_905_ecustom--RepaymentsOfExpensesToRelatedParty_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zsVuqgKLl8Hk" title="Repayments of expenses to related party">0 and $<span id="xdx_90A_ecustom--RepaymentsOfExpensesToRelatedParty_c20250101__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zjCOCGBBOd19" title="Repayments of expenses to related party">120,946, respectively. As of June 30, 2026 and December 31, 2025, the balance owed to former chief financial officer $<span id="xdx_909_eus-gaap--OtherLiabilitiesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zpIN0eqbjFsc" title="Balance owed"><span id="xdx_90A_eus-gaap--OtherLiabilitiesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_z7qxS2bOMqc7" title="Balance owed">0. During the six months ended June 30, 2026 and 2025, the chief executive officer paid $<span id="xdx_901_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBaWuYgay9K6" title="Expenses paid on the company's behalf">21,313 and $<span id="xdx_904_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20250101__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zZy3G4atxTCe" title="Expenses paid on the company's behalf">0 of expenses on the Company’s behalf and was repaid $<span id="xdx_902_ecustom--RepaymentsOfExpensesToRelatedParty_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z4nTxh4zgPwd" title="Repayments of expenses to related party">21,313 and $<span id="xdx_90C_ecustom--RepaymentsOfExpensesToRelatedParty_c20250101__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zoHLMoC64Zib" title="Repayments of expenses to related party">0, respectively. As of June 30, 2026 and December 31, 2025, the balance owed to chief executive officer $<span id="xdx_909_eus-gaap--OtherLiabilitiesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zcWDRtce8E38" title="Balance owed">0 and $<span id="xdx_902_eus-gaap--OtherLiabilitiesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zsBKspKixEF1" title="Balance owed">0, respectively. Accruals As of June 30, 2026, the accrued related party salary and accrued interest expense was $124,577 and $15,495, respectively. As of December 31, 2025, the accrued related party salary and accrued interest expense was $97,000 and $12,307, respectively. During the period ended June 30, 2026, the board approved a health stipend for the Company’s Chief Executive Officer, Saul Leal, in the amount of $<span id="xdx_90E_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260101__20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z9pAUZcMIdK9" title="Health stipend amount per month">2,800 per month with a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zA2MOUx84ru1" title="Cumulative interest rate">5% cumulative interest on the unpaid balance. The stipend and interest were retroactively applied back to commencing of service in July 2022. As of June 30, 2026, the Company accrued $<span id="xdx_90A_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z2XWrN7WZozg" title="Accrued stipend">134,400 for the stipend and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z8HvO4Gk8xqg" title="Accrued interest for stipend">14,600 for the accrued interest. Accrued commissions During the period ended June 30, 2026, the board approved a sales commission of 6% stipend for the Company’s Chief Executive Officer, Saul Leal. During the period ended June 30, 2026, the Company accrued sales commission for Saul in the amount of $62,150. As of June, 30, 2026, the accrued sales commission to Saul was $62,150. Advances On February 2, 2026, the Company’s Chief Executive Officer advanced the Company $25,000 to be used for operating expenditures. The advance is due on demand and accrues interest at a rate of 14%. During the six months ended June 30, 2026, the Company repaid $6,000 of the advance balance. As of June 30, 2026, the advance and accrued interest balance was $19,000 and $1,419, respectively. Secure promissory note On January 27, 2026, the Company entered into a promissory note agreement for $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zs8l1VcUg7k" title="Promissory note">80,000 with Roy Chestnutt, Company’s Director. The Company recognized debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zcaYENzdQka7" title="Debt discount">1,612 at the issuance of the note. Pursuant to the agreement, the interest on the promissory note shall equal to <span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zBx9cLx2S6yi" title="Restricted common stock issuable of interest">16,000 shares of restricted common stock of the Company. Both the principal balance and the shares are payable on February 1, 2026. As of February 1, 2026, the Company paid the principal balance of $<span id="xdx_900_eus-gaap--DebtInstrumentRepaidPrincipal_c20260201__20260201__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zPtavpgKtHTe" title="Principal balance paid">80,000 and issued the <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260201__20260201__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z5jDSQsefDGg" title="Common stock issued for interest">16,000 common shares for the accrued interest. As of June 30, 2026, the principal balance of the promissory note was $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pid_c20260630__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zaWBaLZR1PW9" title="Principal balance">0. As of June 30, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the years ended December 2025 and 2024, the Company entered into multiple secured promissory notes agreements with the Company’s former Chief Executive Officer, Rowland Day, for total proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zYJ4MCYstx0f" title="Expenses paid on the company's behalf"><span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zYRrUmbidWql" title="Expenses paid on the company's behalf">883,500. The notes were secured by the assets of the Company and accrued interest at the rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zPUkvfz7bCt8" title="Interest rate"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zISbOPvhs61a" title="Interest rate">14% per annum. During the year ended December 31, 2025 and as part of the separation agreement with Rowland Day, the Company repaid the outstanding principal balance of $<span id="xdx_907_eus-gaap--DebtInstrumentRepaidPrincipal_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zOJErUkt0WVc" title="Principal balance paid">802,450 and the accrued interest of $<span id="xdx_90B_eus-gaap--InterestPaid_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zIqWkZj8NV5e" title="Interest paid">101,225. As of June 30, 2026 and December 31, 2025, the related party senior secured promissory notes payable principal balance was $<span id="xdx_90B_eus-gaap--NotesPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zjAy056JgpEi" title="Notes payable principal balance">0 and $<span id="xdx_902_eus-gaap--NotesPayable_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zISPn1SJbCV9" title="Notes payable principal balance">0, respectively, with accrued interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_c20260630__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zlmpa9AGWxz3" title="Accrued interest">0 and $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z2os7xub6a32" title="Accrued interest">0, respectively. Settlement Agreement Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of up to <span id="xdx_90A_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zolnCJbKzyrc" title="Stock issued during the period, shares">4,309,710 shares of the Company’s Series B-1 Preferred Stock and <span id="xdx_907_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLMZFfcAQC2a" title="Number of shares authorized for repurchase">307,647 shares of common stock, at per-share prices ranging from $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zdahinATm6Wa" title="Share price">0.605-$<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_zbC3YmUADMDk" title="Share price">0.66 for the preferred shares and $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zUQPwjode1z5" title="Share price">0.055-$<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_zfWi6W9KIGGf" title="Share price">0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company paid an additional $100,000 to Rowland as an extension fee. On March 27, 2026, the Company paid $150,000 as a deposit on the stock re-purchase to Rowland. Additionally, through issuance of two notes dated March 26, 2026 (Note 6), $700,000 was wired directly by the noteholder to Rowland as a deposit on the stock re-purchase. On April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260410__20260410__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zzO1Pd1sjNbh" title="Consideration received on transaction">2,850,000. During the period ended June 30, 2026, the Company paid $2,000,000 to Rowland for the share re-purchase and the $100,000 extension fee. Convertible notes payable During the year ended December 31, 2025 and the period ended June 30, 2026, the Company issued a series of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zalBuJWiFEie" title="Interest rate"><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zA0A9uBTbt07" title="Interest rate">0% interest convertible notes payable to a director, a director nominee and two relatives of a the director nominee in exchange for $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20260101__20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zdHrML3EVsMb" title="Proceeds from convertible notes">450,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. During the period ended June 30, 2026, the Company and four noteholders amended the terms of the convertible note agreements to retroactively accrue interest on their notes from the effective date of the agreements on a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zZZuDfdYdZ9" title="Debt effective percentage">10%. During the period ended June 30, 2026, the Company recorded and accrued interest expense on the convertible notes in the amount of $<span id="xdx_905_eus-gaap--InterestExpense_c20260101__20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z8sDiFoehbwk" title="Accrued interest expense">31,452. Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of June 30, 2026 and December 31, 2025, the convertible notes payable principal balance was $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zKmIJI6djAS2" title="Convertible note payable related party">450,000 and $<span id="xdx_908_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zHgY4OtW3lcf" title="Convertible note payable related party">250,000, respectively, and the accrued interest was $<span id="xdx_90F_eus-gaap--InterestPayableCurrent_iI_c20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zR3paXoYncn8" title="Accrued interest">31,452 and $<span id="xdx_90A_eus-gaap--InterestPayableCurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z8LTChwiOIB" title="Accrued interest">0, respectively. The Company calculated imputed interest on the zero percent convertible notes using an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20260101__20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zldx7yxSDV71" title="Interest rate">14% and recorded to additional paid-in-capital. As of June 30, 2026 and December 31, 2025, the Company recorded imputed interest of $<span id="xdx_90B_ecustom--ImputeInterest_iI_c20260630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z5X46S7itfUa" title="Impute interest">6,904 and $<span id="xdx_906_ecustom--ImputeInterest_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zENRzIv6IAba" title="Impute interest">30,359, respectively. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of June 30, 2026. As June 30, 2026, the matured convertible notes would potentially be converted into 3,007,472 common shares. Schedule of Convertible Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260630_zVDwpH5cKp8f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251225_zpvBqzYVbzBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--ConvertibleNotesPayableRelatedPartyCurrent_iI_maCDz2aq_z8eRa6fYeZrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Convertible notes payable, relate party</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">250,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebt_iTI_mtCDz2aq_z7ovrMSy9GUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total convertible notes payable, relate party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebtCurrent_iNI_di_zrdGldU4lAn3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebtNoncurrent_iI_zP2uXcSLEjRb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term convertible notes payable, relate party, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

195118

0 120946

21313

21313 0

124577

15495

97000

12307

2800

0.05

134400

14600

0.06

62150

25000

0.14

6000

19000

1419

80000

1612

16000

80000

16000

883500

0.14

802450

101225

917966

408486

4309710 307647

0.605

0.66

0.055

0.06

100000

150000

700000

4166667

0.66

2850000

2000000

100000

450000

(x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

0.10

31452

450000

250000

31452

0.14

6904 30359

3007472

Schedule of Convertible Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260630_zVDwpH5cKp8f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251225_zpvBqzYVbzBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--ConvertibleNotesPayableRelatedPartyCurrent_iI_maCDz2aq_z8eRa6fYeZrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Convertible notes payable, relate party</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">250,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebt_iTI_mtCDz2aq_z7ovrMSy9GUc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total convertible notes payable, relate party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebtCurrent_iNI_di_zrdGldU4lAn3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebtNoncurrent_iI_zP2uXcSLEjRb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term convertible notes payable, relate party, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

450000 250000

450000

250000

450000

250000

Note 5. Convertible Notes Payable In December 2024, the Company issued convertible notes payable to three investors in exchange for $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20241201__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zm8B7kOJjdYl" title="Proceeds from convertible notes">650,000. During the year ended December 31, 2025, the Company issued <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zIA0J11dG6Qb" title="Interest rate">0% interest convertible notes payable to three investors in exchange for $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZ01YfZxlkYe" title="Proceeds from convertible notes">290,000. convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20250101__20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember_zmJFljFGjB7b" title="Convertible price, description">(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. During the period ended June 30, 2026, the Company and four noteholders amended the terms of the convertible note agreements to retroactively accrue interest on their notes from the effective date of the agreements on a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zOXCLtYEQzv8" title="Debt effective percentage">10%. During the period ended June 30, 2026, the Company recorded and accrued interest expense on the convertible notes in the amount of $19,518. Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of June 30, 2026 and December 31, 2025, the convertible notes payable principal balance was $940,000 and $940,000, respectively, and the accrued interest was $19,518 and $0, respectively. The Company calculated imputed interest on the zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. As of June 30, 2026 and December 31, 2025, the Company recorded imputed interest of $55,233 and $119,040, respectively. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of June 30, 2026. As June 30, 2026, the matured convertible notes would potentially be converted into <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTv2XZ122YSe" title="Common stock capital shares reserved for future issuance">5,538,201 common shares. On November 3, 2025, the Company entered into a Convertible Notes Agreement and a Warrant Purchase Agreements (the “Purchase Agreements”), dated as of October 31, 2025, with two investors (the “Holders”) for their purchase of (i) 14% convertible secured promissory notes of the Company in the aggregate original principal amount of $2,000,000 payable on October 31, 2028 (the “Notes”) with a fixed conversion price of $0.08 and (ii) 5-year warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251031__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_z28aolFy05Sg" title="Warrants to purchase common stock">6,000,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds were used to repay the amounts outstanding under those certain 14% secured promissory notes and credit card balances to the former President of the Company in the amounts of $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_c20251031__20251031__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_zhUVNlJjAHHe" title="Promissory notes repaid">917,966 and $<span id="xdx_909_eus-gaap--RepaymentsOfOtherDebt_c20251031__20251031__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_zJzahqZpNhd9" title="Payment of credit card balances">408,486, respectively. The remainder of the proceeds were used for working capital and general corporate purposes. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. On February 11, 2026, the Company entered into two Promissory Note Agreements (the “Additional Notes”) with the Holders for an additional $200,000. The interest on the promissory note was equal to <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember_z7QfdhAEVO06" title="Common stock issuable for interest">125,000 shares of common stock of the Company for each note. Both the principal balance and the shares are payable on February 26, 2026. Per the agreement, If the loans were note repaid when matured, the Company will issue an additional <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember_zOoJboOAl6Ad" title="Stock issued during period shares additional new issues">125,000 shares of common stock for each note and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember__us-gaap--AwardDateAxis__custom--ThreeMonthsThereafterMember_zHvglYgAVuS1" title="Common stock issuable on default">125,000 shares every three months thereafter. On March 17, 2026, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Amendment” or “Amended and Restated Note”) with the Holders. Pursuant to the Amended and Restated Note, the Company and the Holders combined the Existing Notes and the Additional Notes in their entirety under the terms of the Amended and Restated Note. Under the Amended and Restated Note, the maturity date of the Existing Notes was amended on March 26, 2026. The Company recognized amortization on the debt discount of $<span id="xdx_90C_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20260101__20260630__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zViw4UOZIsh2" title="Amortization on debt discount">612,388 during the period ended June 30, 2026. As of June 30, 2026 and December 31, 2025, the principal balance of the notes was $2,200,000 and $2,000,000. As of June 30, 2026 The unamortized debt discount was $0. Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260630_zCapnhaUtppc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20251231_z9zHXLTdGhK2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zK4aMpXahyxl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Convertible notes payable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">3,140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,327,612</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_zB8iYbiEqAgi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,327,612</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayablesCurrent_iNI_di_zMaDmxPHThGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_z9ihfIMLVeAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term convertible notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,387,612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

650000

290000

(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

0.10

19518

940000

19518 0

0.14

55233 119040

5538201

0.14

2000000

0.08

P5Y

6000000

0.08

0.14

917966

408486

200000

125000

612388

2200000

2000000

Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260630_zCapnhaUtppc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20251231_z9zHXLTdGhK2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zK4aMpXahyxl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Convertible notes payable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">3,140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,327,612</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_zB8iYbiEqAgi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,327,612</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayablesCurrent_iNI_di_zMaDmxPHThGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_z9ihfIMLVeAe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term convertible notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,387,612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3140000 2327612

3140000

2327612

3140000 940000

1387612

Note 6. Promissory Notes On September 11, 2025, the Company entered into a Promissory Note for a principal amount of $353,050 with the Company receiving cash proceeds of $300,000. The Company recognized debt discount of $53,050 at the issuance of the notes. The note matures on August 30, 2026, and bears a one-time interest of 12% or $42,366. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date. During the period ended June 30, 2026, the Company repaid $261,257 and $35,305 of the principal balance and accrued interest, respectively. The Company recognized amortization on the debt discount of $26,525 during the period ended June 30, 2026. As of June 30, 2026 and December 31, 2025, the principal balance of the note was $91,793 and $353,050 and the accrued interest was $<span id="xdx_90F_eus-gaap--AccruedSalariesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteOneMember_ztGKiEnkUlI3" title="Accrued salary">7,061 and $<span id="xdx_90E_eus-gaap--AccruedSalariesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteOneMember_z4ZFM4Wu5OY7" title="Accrued salary">42,366, respectively. On October 13, 2025, the Company entered into a Promissory Note for a principal amount of $76,550 with the Company receiving cash proceeds of $70,000. The Company recognized debt discount of $18,550 at the issuance of the notes. The note matures on August 15, 2026 and bears a one-time interest of 15% or $13,282. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date. During the period ended June 30, 2026, the Company repaid $54,413 and $9,962 of the principal balance and accrued interest, respectively . The Company recognized amortization on the debt discount of $11,130 during the period ended June 30, 2026. As of June 30, 2026 and December 31, 2025, the principal balance of the note was $22,138 and $76,550 and the accrued interest was $<span id="xdx_903_eus-gaap--AccruedSalariesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteTwoMember_ziW5yrliMI4c" title="Accrued salary">3,321 and $<span id="xdx_900_eus-gaap--AccruedSalariesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteTwoMember_zubvElSw5bz1" title="Accrued salary">13,282, respectively. On March 26, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zHsk9zYi63ph" title="Interest rate">14% secured promissory notes of the Company in the aggregate original principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zpc30r3HS553" title="Principal amount">700,000 payable on April 17, 2026 and (ii) <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zSQ3WZ1tPA46" title="Warrants term">5-year warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_z3xtdF2mnHf5" title="Warrants to purchase common stock">3,300,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zphHE4dCq11i" title="Exercise price">0.08. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. The warrants had a relative fair value of $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zd5YIiCUm8X3" title="Fair value of warrants">252,834, which was recorded as a discount on the note. During the period ended June 30, 2026, the Company repaid $700,000 and $10,897 of the principal balance and accrued interest, respectively. The Company recognized amortization on the debt discount of $252,834 during the period ended June 30, 2026 on the promissory notes. As of June 30, 2026, the principal balance and accrued interest of the note was $0 and $<span id="xdx_90F_eus-gaap--AccruedSalariesCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteThreeMember_zeYB4qIUIppg" title="Accrued salary">0, respectively. On May 13, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zNppfa02GpBh" title="Interest rate">14% secured promissory notes of the Company in the aggregate original principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zx2tmjIN8W9l" title="Principal amount">170,000 payable on May 26, 2026 and (ii) <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zU0Apw3xpKpi" title="Warrants term">5-year warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zsuqb7XeRbr9" title="Warrants to purchase common stock">1,402,500 shares of the Company’s common stock at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zw9NWlSPlqk9" title="Exercise price">0.14. The warrants had a relative fair value of $<span id="xdx_90E_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zPUDVJ0ctHrf" title="Warrant fair value">112,930, which was recorded as a discount on the note. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders warrants to purchase <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260513__20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zavVrPGt9c5j" title="Number of shares issued">3,718,750 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. The Company defaulted on the May 13, 2026 notes and issued a <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zgcW6Fi7Vo9d" title="Warrants term">5-year warrants to purchase <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260513__20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zssqQUaBsWEi" title="Number of shares issued">3,718,750 shares of the Company’s common stock an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zgOky2CZkiYf" title="Exercise price">0.14. The warrants had a fair value of $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zh3gC0vogDTe" title="Fair value of warrants">817,604, which was recorded as an interest expense in additional paid-in-capital. The Company recognized amortization on the debt discount of $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteFourMember_z27rBrfIaTQ5" title="Amortization of debt discount">112,930 during the period ended June 30, 2026 on the promissory notes. As of June 30, 2026, the principal balance and accrued interest of the note was $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteFourMember_zTTNHSIShM5l" title="Principal balance">170,000 and $1,118, respectively. On May 28, 2026, the Company entered into a Promissory Note for a principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20260528__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zRV52pSxqxk1" title="Principal amount">203,550 with the Company receiving cash proceeds of $170,000. The Company recognized debt discount of $33,550 at the issuance of the notes. The note matures on May 30, 2026 and bears a one-time interest of 12% or $24,426. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date. The Company recognized amortization on the debt discount of $2,796 during the period ended June 30, 2026 on the promissory notes. As of June 30, 2026, the principal balance and accrued interest of the note was $80,000 and $24,426, respectively. On June 12, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zMbznKyrNx9k" title="Interest rate">14% secured promissory notes of the Company in the aggregate original principal amount of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zAmh1IAuRBHd" title="Principal amount">80,000 payable on December 31, 2026 and (ii)<span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zKlnGH9qyINk" title="Warrants term"> 5-year warrants to purchase <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zaqdTvQ9LR21" title="Warrants to purchase common stock">1,131,428 shares of the Company’s common stock at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_z4ege3to8g13" title="Exercise price">0.14. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders a warrant to purchase <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260612__20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zIoTuYFKWV0c" title="Number of shares issued">3,000,000 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. The warrants had a relative fair value of $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260612__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zOXpjbHeisD2" title="Fair value of warrants">53,761, which was recorded as a discount on the note. The Company recognized amortization on the debt discount of $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteSixMember_z5rugLW8JkR" title="Amortization of debt discount">4,480 during the period ended June 30, 2026 on the promissory notes. As of June 30, 2026, the principal balance and accrued interest of the note was $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20260630__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteSixMember_zeAEZ2l4Hgi8" title="Principal balance">80,000 and $395, respectively. Schedule of Promissory Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zPeM9vagRidf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zKUUKAbvquM1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_408_ecustom--PromissoryNotePayableNet_iI_pp0p0_zXJaKZlRJMmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Promissory notes payable, net</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">475,821</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">380,321</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayable_iTI_pp0p0_mtNPz031_zkC1feRwkz9j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total Promissory notes payable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">475,821</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">380,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iNI_pp0p0_di_zE1EgX95H9h8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(475,821</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(380,321</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--LongTermNotesPayable_iI_pp0p0_zIZ8MmDmEsVe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term Promissory notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of June 30, 2026, the unamortized debt discount was $91,659. As of December 31, 2025, the Company had unamortized debt discount of $49,279.

353050

300000

53050

0.12

42366

0.22

Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date

261257

35305

26525

91793

353050

7061

42366

76550

70000

18550

0.15

13282

0.22

54413

9962

11130

22138

76550

3321

13282

0.14

700000

P5Y

3300000

0.08

252834

700000

10897

252834

0.14

170000

P5Y

1402500

0.14

112930

3718750

P5Y

3718750

0.14

817604

112930

170000

1118

203550

170000

33550

2026-05-30

0.12

24426

0.22

2796

80000

24426

0.14

80000

P5Y

1131428

0.14

3000000

53761

4480

80000

395

Schedule of Promissory Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260630__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zPeM9vagRidf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zKUUKAbvquM1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_408_ecustom--PromissoryNotePayableNet_iI_pp0p0_zXJaKZlRJMmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Promissory notes payable, net</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">475,821</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">380,321</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayable_iTI_pp0p0_mtNPz031_zkC1feRwkz9j" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total Promissory notes payable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">475,821</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">380,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iNI_pp0p0_di_zE1EgX95H9h8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(475,821</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(380,321</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--LongTermNotesPayable_iI_pp0p0_zIZ8MmDmEsVe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term Promissory notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 475821 380321

475821

380321

475821

380321

91659

49279

Note 7. Equity The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors. Common Stock As of June 30, 2026 and December 31, 2025, there were 38,890,943 and 38,890,943 shares issued and outstanding, respectively. Preferred Stock Series A Convertible Preferred Stock Our board of directors designated <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zsefRVpvuk6k" title="Preferred stock, shares authorized">2,068 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zCaQIOcvhqZ2" title="Preferred stock, par value">0.001. Series A has liquidation and dividend preferences. Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. Each share of Series A is convertible on a 1 to<span id="xdx_907_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zzM77XtjBJA8" title="Preferred stock, convertible terms"> 1.25 common share basis. As of each of June 30, 2026 and December 31, 2025, there were <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zLDnDe5Su07f" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zu8niVbgRw" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_z3k14tryDycg" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zOaWlfru7R4k" title="Preferred stock, shares outstanding">2,068 shares of Series A issued and outstanding. Series B-1 Convertible Preferred Stock Our board of directors designated 8,619,420 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with a par value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zuUHLrCewgTc" title="Preferred stock, par value">0.001. Series B-1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible. <span id="xdx_90C_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zjO847xzoQ67" title="Preferred stock, conversion terms">Each share of Series B-1 is convertible on a 1 to 11 common share basis. On September 30, 2023, the Articles of Incorporation of the Company were amended to remove the redemption right of the Series B-1. The Company’s Articles of Incorporation require <span id="xdx_905_ecustom--PercentageOfOutstandingVotes_dp_uPure_c20230930__20230930__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zWNR3PF95vjc" title="Outstanding votes percent">51% of the outstanding votes of the Series B-1 to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. As of June 30, 2026 and December 31, 2025, there are <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zi0HUzuCF8Jj" title="Preferred stock, shares outstanding">5,252,753 and <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zsjTX5VPmKdf" title="Preferred stock, shares outstanding">8,619,420 shares of Series B-1 issued and outstanding, respectively. Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of up to <span id="xdx_90A_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zG3lwaHzOiIk" title="Stock issued during the period, shares">4,309,710 shares of the Company’s Series B-1 Preferred Stock and <span id="xdx_907_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxlq0cPO1SZ4" title="Number of shares authorized for repurchase">307,647 shares of common stock, at per-share prices ranging from $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zVeG3GoLOntk" title="Share price">0.605-$<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_zQb3Y8JqSzRh" title="Share price">0.66 for the preferred shares and $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_ziYckdY5ClN9" title="Share price">0.055-$<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_z0463aVB8Xwb" title="Share price">0.06 for the common shares, depending on the repurchase date. On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company paid an additional $100,000 to Rowland as an extension fee. On April 10, 2026, the Company purchased 4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $0.66 per Series B-1 Preferred share for a total cash consideration of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260410__20260410__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z5dwLKsfLQ22" title="Consideration received on transaction">2,850,000. During the period ended June 30, 2026, the Company paid $2,150,000 in cash consideration to Rowland for the share re-purchase and the $100,000 extension fee and $<span id="xdx_901_eus-gaap--RepaymentsOfRelatedPartyDebt_c20260410__20260410__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zgzqYAu6gWdb" title="Payment of related party">700,000 was wired directly by the noteholder to Rowland. On March 9, 2026, the board of directors approved the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260309__20260309__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zM6Fyx6CAgjd" title="Shares issued for bounus">800,000 share of Series B-1 Convertible Preferred Stock to Mr. Leal as a bonus. The <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260309__20260309__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zj6t5KUoUUlg" title="Shares issued for bounus">800,000 shares of Series B-1 convertible preferred stock valued at the at-converted value of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20260309__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zkH8RIIHcb2d" title="Converted price per share">0.13 per share with a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260309__20260309__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zEoL0rXpmIo7" title="Value of shares issued for bonus">1,129,920. During the three months ended June 30, 2026, the Company engaged an independent valuation specialist to determine the fair value of the Series B-1 Preferred Stock. The valuation utilized an Option Pricing Model (OPM)], incorporating significant unobservable inputs including a discount for lack of marketability of <span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDiscountMarketability_pid_dp_uPure_c20260401__20260630_fKDIp_zaCSMzJ7rmc2" title="Discount for lack of marketability">3.58%, an expected volatility of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20260401__20260630_fKDIp_zIP4e7HDRxdl" title="Expected volatility">212.5%, and an expected time to liquidity event of 3.00 years. Based on this assessment, the estimated fair value of the Series B-1 Preferred Stock was determined to be $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260401__20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zajM0iAcb4F7" title="Value of shares issued for bonus">1,172,960 or $<span id="xdx_903_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zvn0NSt1gZg3" title="Converted price per share">1.4662 per share. Series B-2 Convertible Preferred Stock Our board of directors designated 3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_zXNTCuPFR2D9" title="Preferred stock, par value">0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended such that no Series B-2 shares are authorized. Series B-2 have no liquidation or dividend preferences. Each share of Series B-2 has voting rights equal to the amount of shares of common stock the Series B-2 is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of June 30, 2026 and December 31, 2025, there are <span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20260630__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_znkFVITk1Yvh" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_z79pTk6Jidyj" title="Preferred stock, shares outstanding">no shares of Series B-2 issued and outstanding. Common Stock Liability Common stock to be issued for cash During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq7N2R33XtMi" title="Number of shares issued for cash">5,222,224 shares of common stock for $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zP1tsWxI5wP2" title="Value of shares issued for cash">740,000 cash. As of June 30, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. In connection with two stock purchase agreements, the Company issued two warrants to purchase <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_z3vSUntx4ZCl" title="Warrant issued">3,127,778 shares of the Company’s common stock. The warrants had a relative fair value of $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zvOP4piTP9lf" title="Fair value of warrants">158,287, which was recorded as a discount on the note. During the period ended June 30, 2026, total amount of shares payable and total value recorded as common stock liability issued for cash was 5,222,224 and $740,000, respectively. Common stock to be issued for interest During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zFUenWlPAw0h" title="Number of shares issued for interest">766,000 shares of common stock in lieu of interest on convertible and promissory notes with a fair value of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pid_c20260101__20260630__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zCPVHPTq9dgc" title="Value of shares issued for interest">116,364. As of June 30, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended June 30, 2026, total amount of shares payable and total value recorded as common stock liability issued for interest on notes was 766,000 and $116,364, respectively. Common stock to be issued for accounts payable settlement During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260101__20260630__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccountsPayableSettlementMember_zRtYz9mmDo03" title="Number of shares issued to settle accounts payable">100,000 shares of common stock to settle an accounts payable balance with a fair value of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pid_c20260101__20260630__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccountsPayableSettlementMember_zojLQLbdvS0f" title="Value of shares issued to settle accounts payable">16,000. As of June 30, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended June 30, 2026, total amount of shares payable and total value recorded as common stock liability issued for accounts payable settlement was 100,000 and $16,000, respectively. Common stock to be issued for service During the period ended June 30, 2026, the Company entered into several consultant agreements where the Company granted the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__srt--TitleOfIndividualAxis__custom--ConsultantMember_zHGaRCiTM0Gl" title="Number of shares issued for serivce">1,613,416 common shares to the consultants. The shares had a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20260101__20260630__srt--TitleOfIndividualAxis__custom--ConsultantMember_zGVMCG1xGMS2" title="Value of shares issued for serivce">301,711. On January 1, 2026, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260101__20260101__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zDP51oCv5WCc" title="Issuance of common shares">10,000 common shares on a monthly basis beginning on the effective date of the agreement. During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zb9v8P7Hf5Qh" title="Issuance of common shares">60,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zGrhLU6EIzTi" title="Stock based compensation">11,406. On December 18, 2025, the Company entered into a six month term consultant agreement where the consultant will receive <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251218__20251218__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_zlO6d5PFJoI9" title="Issuance of common shares">7,000 common shares on a monthly basis beginning on the effective date of the agreement. During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_z3E8KRLXoXHd" title="Issuance of common shares">42,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_zBz0ixN6rEd1" title="Stock based compensation">7,482. On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250801__20250801__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zIKppoXXEB72" title="Issuance of common shares">7,000 common shares on a monthly basis beginning on the effective date of the agreement. On December 15,2025, the Company entered into an amendment to the consultant agreement to increase the number of monthly common shares to <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zrtNcLjKkTx" title="Issuance of common shares">14,000 common shares per month beginning on January 1, 2026. In 2025, the Company granted the issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_z5S9iocSVQU1" title="Issuance of common shares">35,000 common shares to the consultant. During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zT4aXLWLd147" title="Issuance of common shares">84,000 common shares to the consultant, having a fair value of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zrw3VJmgLUXe" title="Stock based compensation">15,973. On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250801__20250801__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_zAsCELP8jcmh" title="Shares issuable for services per month">7,000 common shares on a monthly basis beginning on the effective date of the agreement. In 2025, the Company granted the issuance of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_zFS3Tvc49f1f" title="Issuance of common shares">35,000 common shares to the consultant. During the period ended June 30, 2026, the Company granted the issuance of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_zMAuV8sHBvY3" title="Number of shares issued for serivce">42,000 common shares to the consultant, having a fair value of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260630__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_zY2uQnwHeY1j" title="Fair value of shares issued for serivce">7,986. As of June 30, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended June 30, 2026, total amount of shares payable and total value recorded as common stock liability issued for service was 1,841,416 and $344,558, respectively. As of June 30, 2026, the total amount of shares payable issued for service was 4,039,416. Restricted Common Stock 2026 Issuance On June 1, 2026, the Company granted the issuance of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20260601__20260601__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zxUZMidBNFY" title="Number of restricted common shares issued">300,000 restricted common shares to an advisor. The restricted common shares vest in six-month equal installments. The restricted common shares had a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260601__20260601__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_z7uOkIPBZdBe" title="Fair value of restricted common shares issued">53,100 or $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zPEyIQUnWnD9" title="Exercise price">0.18 per share. On March 30, 2026, the Company granted the issuance of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_z7ilmASCQdH" title="Number of restricted common shares issued">323,334 restricted common shares to an advisor. <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_zew276k9fVId" title="Restricted common shares vested">83,334 restricted common shares vest immediately and the remaining balance vests in twelve months equal instalments. The restricted common shares had a fair value of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_z0H01FnkI3a1" title="Fair value of restricted common shares issued">43,973 or $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_znswdwqo0uWi" title="Exercise price">0.14 per share. On March 1, 2026, the Company granted the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20260301__20260301__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_ziGGgGE2YL2e" title="Number of restricted common shares issued">180,000 restricted common shares to an advisor. The restricted common shares vest in six-month equal installments. The restricted common shares had a fair value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260301__20260301__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_zxKqtnkUKB27" title="Fair value of restricted common shares issued">24,066 or $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260301__20260301__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_zHitzAYGbAPd" title="Exercise price">0.11 per share. 2025 Issuance – Recorded in 2026 On December 1, 2025, the Company granted the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20251201__20251201__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_z5M0z3KTj814" title="Restricted common shares">24,000 restricted common shares to an advisor. The restricted common shares vest in six-month equal installments. The restricted common shares had a fair value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20251201__20251201__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_zd8ChxuOBXcb" title="Fair value of restricted common shares issued">5,712 or $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20251201__20251201__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_zJwoi8w08K9" title="Exercise price">0.24 per share. <p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zfSFwHGf8Ss" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The following table summarizes the restricted common stock activity for the six months ended June 30, 2026: Schedule of Restricted Common Stock Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Awards</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025 </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zS2XCUzVXWAk" style="width: 16%; text-align: right" title="Number of Restricted Shares, Outstanding Beginning balance">460,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCKhv8ALbcA1" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance">0.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsrXYnhRhwTe" style="text-align: right" title="Number of Restricted shares, Granted">827,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqtJ1hppuw9f" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited/Cancelled </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zZh1ls56uHh4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Restricted shares, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvCnBTujZr9k" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5NxBav5S458" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Shares, Outstanding Ending balance">1,287,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zS0q3RfGxVU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance">0.24</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Vested, June 30, 2026 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zuaHZfXxvNk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Shares, Vested Ending balance">767,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOw9ftA0LXE6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Vested Ending balance">0.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> During the three months ended June 30, 2026, the Company recognized $48,368 of stock-based compensation expense related to outstanding restricted common stock. During the six months ended June 30, 2026, the Company recognized $72,370 of stock-based compensation expense related to outstanding restricted common stock. At June 30, 2026, the Company had $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsjOqNnByjPc" title="Compensation expense remaining to be recognized, awards excluding stock options">84,822 of unrecognized compensation expense related to outstanding restricted common stock, which will be recognized over approximately <span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_pid_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zDlUPQEvezlh" title="Compensation expense remaining to be recognized, period">1.00 year. Stock Warrants During the period ended June 30, 2026, the Company issued <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMj81sWTAD4d" title="Warrant issued">3,300,000 and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRXrroZ15tV1" title="Warrant issued">2,533,928 common stock warrants with exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z6Dr3UjFbI2e" title="Exercise price">0.08 and $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zWu4jFNLaohe" title="Exercise price">0.14, respectively, in conjunction with convertible secured promissory notes agreements. The warrants had a relative fair value of $419,525, which was recorded as a discount on the note payable. During the period ended June 30, 2026, the Company issued <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zOEm01NJ5mH9" title="Warrant issued">3,127,778 common stock warrants with exercise price of $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zxco6t8xCPKg" title="Exercise price">0.18 in conjunction with stock purchase agreements. During the period ended June 30, 2026, the Company defaulted on the May 13, 2026 notes and issued a warrant to purchase <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260513__20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zmPuRpxAB0ki" title="Number of shares issued">3,718,750 shares of the Company’s common stock an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_znMKkBW8mIBl" title="Exercise price">0.14. The warrants had a fair value of $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260513__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9CHTxYrdn8f" title="Fair value of warrants">817,603, which was recorded as an interest expense and additional paid-in-capital. In connection with the April 8, 2026 Reseller Agreement, In connection with the Reseller Agreement, the Company granted the issuance of a 10ten-year warrant to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPmZeJzjYyf6" title="Warrant purchase shares">22,222,222 shares of common stock with exercise price of $0.135. The warrant had a fair value of $2,588,313, which was recorded as a discount against the $3,000,000 pre-payment received from the customer. The customer warrant was calculated using the Black-Scholes method over the expected terms and the following assumptions: volatility of 176.81%, exercise price of $0.135 and risk-free rate of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dp_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zTOzaNl5fhg7" title="Warrants and rights outstanding, measurement input">4.29%. <p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ztmX5DuE7Lzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The relative fair value of the warrants was estimated using a Black-Scholes model with the following assumptions: Schedule of Fair Value of Warrants Estimated Using Black-Scholes Model <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left"></td><td style="text-align: right">$<span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zw8ar9v7YYb9" title="Fair value of common stock on measurement date">0.11 - $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zQjvmiBCuKj3" title="Fair value of common stock on measurement date">0.22 per share </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate (1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_fKDEp_zpR5mr5YxCx2" title="Risk free interest rate">4.08% – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_fKDEp_zKmV0jdEVsvl" title="Risk free interest rate">4.29 </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_fKDIp_zACJ4jppMor7" title="Volatility">157.44% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_fKDIp_zdMbdRJ4IAB7" title="Volatility">302.35 </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Dividend yield (3)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDMp_zT6hTOlvypfl" title="Dividend yield">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z2V8Pv2GgH9c" title="Warrants measurement input">1.00 – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zMa5mAKX7CGf" title="Warrants measurement input">10.00 years </td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table> The following table summarizes the stock warrant activity for the six months ended June 30, 2026: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHA821nG2EPl" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">6,350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4Ysk4Jblzrc" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2TbwBH3TXEk" style="text-align: right" title="Warrants outstanding, granted">34,902,678</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRpqPTLHiTAh" style="text-align: right" title="Weighted average exercise price per share, granted">0.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0KWViTrbfMd" style="text-align: right" title="Warrants outstanding, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxhiBxFKekKa" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrCg4fPiTPMk" style="text-align: right" title="Warrants outstanding, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhnbbmuznS86" style="text-align: right" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEbqJ1S4cEIi" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0MneEd9rK17" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHHCZWSPVzy4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">41,252,678</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHfk8QfhGjb7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of June 30, 2026 the outstanding and exercisable warrants have a weighted average remaining term of <span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zgE4DtF2AdVc" title="Warrants outstaning and exercisable, weighted average remaining term">7.12 with an intrinsic value of $<span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUpbJ7Di77Ii" title="Exercisable, intrinsic value">789,991. Stock Options On February 23, 2026, the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zLt74Nlf9sJ6">450,000 options to employees. The options issued have a <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zU3fcGq91o4c" style="display: none">1one-year term at an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zY9Wqm1hMfue" title="Options exercise price">0.18. The options issued to the employees vest immediately on the date of issuance. The total fair value of these option grants at issuance was $<span id="xdx_907_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_pid_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z3GrQvu8kmmf" title="Fair value of option granted">15,988. The Company valued the stock options using the Black-Scholes model with the following key assumptions: <p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zeffctYRZCUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Schedule of Stock Options Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left"></td><td style="text-align: right">$<span id="xdx_900_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zebWErIx86Nd" title="Fair value of common stock on measurement date">0.16 per share </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_909_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zUg4oTMd9Lei" title="Risk free interest rate">3.50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDIp_zpgzzj7Bhyue" title="Volatility">67.73</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zguIZPnK9Nfh" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zEn4XygU3F7i" title="Options measurement input">0.9 years </td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table> During the three months ended June 30, 2026, the Company recognized $90,566 of expense related to outstanding stock options. During the six months ended June 30, 2026, the Company recognized $197,121 of expense related to outstanding stock options. The following table summarizes the stock option activity for the six months ended June 30, 2026: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYxKuVapnuL6" style="width: 16%; text-align: right" title="Options outstanding, Balance">5,465,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zRmwjIOjI7Yb" style="width: 16%; text-align: right" title="Weighted average exercise price, Balance">0.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbXdR4QR9Pma" style="text-align: right" title="Options outstanding, Granted">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zRRzHdeQVX89" style="text-align: right" title="Weighted average exercise price, Granted">0.18</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_z47xeZxcaa3c" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNIQ0XguyhQe" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7mzqaY3Pfp9" style="text-align: right" title="Options outstanding, Forfeited">(1,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5J3JxazUHpc" style="text-align: right" title="Weighted average exercise price, Forfeited">0.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zedsK5PtSjih" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">(100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zciRhbAxVYZe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.75</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zbYAz3O47z53" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">4,815,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zf834A562yJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zgYn85XUTON5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">3,211,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNYVTTN9CfWg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of June 30, 2026, the outstanding and exercisable options have a weighted average remaining term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zKLL89kfqaK1" title="Weighted average remaining term outstanding"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zv3SgoYl89t3" title="Weighted average remaining term, exercisable">3.73 with an intrinsic value of $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zTEFeowshBMe" title="Exercisable, intrinsic value">0.

500000000

0.001

50000000

0.001

38890943

2068

0.001

1.25

2068

8619420

0.001

Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible

Each share of Series B-1 is convertible on a 1 to 11 common share basis

0.51

5252753

8619420

4309710 307647

0.605

0.66

0.055

0.06

100000

4166667

0.66

2850000

2150000

100000

700000

800000

0.13

1129920

0.0358

2.125

P3Y

1172960

1.4662

3107438

0.001

5222224

740000

3127778

158287

5222224

740000

766000

116364

766000

116364

100000

16000

100000

16000

1613416

301711

10000

60000

11406

7000

42000

7482

7000

14000

35000

84000

15973

7000

35000

42000

7986

1841416

344558

4039416

300000

53100

0.18

323334

83334

43973

0.14

180000

24066

0.11

24000

5712

0.24

<p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zfSFwHGf8Ss" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The following table summarizes the restricted common stock activity for the six months ended June 30, 2026: Schedule of Restricted Common Stock Activity <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Restricted Stock Awards</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Grant Date Fair Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025 </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zS2XCUzVXWAk" style="width: 16%; text-align: right" title="Number of Restricted Shares, Outstanding Beginning balance">460,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zCKhv8ALbcA1" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance">0.40</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsrXYnhRhwTe" style="text-align: right" title="Number of Restricted shares, Granted">827,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqtJ1hppuw9f" style="text-align: right" title="Weighted Average Grant Date Fair Value, Granted">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited/Cancelled </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zZh1ls56uHh4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Restricted shares, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvCnBTujZr9k" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z5NxBav5S458" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Shares, Outstanding Ending balance">1,287,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zS0q3RfGxVU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance">0.24</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Vested, June 30, 2026 </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zuaHZfXxvNk3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Shares, Vested Ending balance">767,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOw9ftA0LXE6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Vested Ending balance">0.29</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

460000

0.40

827334

0.15

1287334

0.24

767334

0.29

48368

72370

84822

P1Y

3300000

2533928

0.08

0.14

419525

3127778

0.18

3718750

0.14

817603

P10Y

22222222

0.135

2588313 3000000

1.7681

0.00135

0.0429

<p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ztmX5DuE7Lzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The relative fair value of the warrants was estimated using a Black-Scholes model with the following assumptions: Schedule of Fair Value of Warrants Estimated Using Black-Scholes Model <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left"></td><td style="text-align: right">$<span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zw8ar9v7YYb9" title="Fair value of common stock on measurement date">0.11 - $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zQjvmiBCuKj3" title="Fair value of common stock on measurement date">0.22 per share </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate (1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_fKDEp_zpR5mr5YxCx2" title="Risk free interest rate">4.08% – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_fKDEp_zKmV0jdEVsvl" title="Risk free interest rate">4.29 </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_fKDIp_zACJ4jppMor7" title="Volatility">157.44% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_fKDIp_zdMbdRJ4IAB7" title="Volatility">302.35 </td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Dividend yield (3)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDMp_zT6hTOlvypfl" title="Dividend yield">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z2V8Pv2GgH9c" title="Warrants measurement input">1.00 – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zMa5mAKX7CGf" title="Warrants measurement input">10.00 years </td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table>

0.11

0.22

4.08

4.29

157.44

302.35

1.00

10.00

The following table summarizes the stock warrant activity for the six months ended June 30, 2026: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHA821nG2EPl" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">6,350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4Ysk4Jblzrc" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2TbwBH3TXEk" style="text-align: right" title="Warrants outstanding, granted">34,902,678</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRpqPTLHiTAh" style="text-align: right" title="Weighted average exercise price per share, granted">0.13</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0KWViTrbfMd" style="text-align: right" title="Warrants outstanding, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxhiBxFKekKa" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrCg4fPiTPMk" style="text-align: right" title="Warrants outstanding, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhnbbmuznS86" style="text-align: right" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEbqJ1S4cEIi" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredWeightedAverageGrantDateFairValue_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0MneEd9rK17" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHHCZWSPVzy4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">41,252,678</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zHfk8QfhGjb7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

6350000

0.15

34902678

0.13

41252678

0.14

P7Y1M13D

789991

450000

P1Y

0.18

15988

<p id="xdx_892_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zeffctYRZCUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Schedule of Stock Options Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left"></td><td style="text-align: right">$<span id="xdx_900_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zebWErIx86Nd" title="Fair value of common stock on measurement date">0.16 per share </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_909_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zUg4oTMd9Lei" title="Risk free interest rate">3.50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDIp_zpgzzj7Bhyue" title="Volatility">67.73</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zguIZPnK9Nfh" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_dtY_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zEn4XygU3F7i" title="Options measurement input">0.9 years </td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table>

0.16

3.50

67.73

0.9

90566

197121

The following table summarizes the stock option activity for the six months ended June 30, 2026: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted- Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zYxKuVapnuL6" style="width: 16%; text-align: right" title="Options outstanding, Balance">5,465,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_zRmwjIOjI7Yb" style="width: 16%; text-align: right" title="Weighted average exercise price, Balance">0.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbXdR4QR9Pma" style="text-align: right" title="Options outstanding, Granted">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zRRzHdeQVX89" style="text-align: right" title="Weighted average exercise price, Granted">0.18</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_z47xeZxcaa3c" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNIQ0XguyhQe" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7mzqaY3Pfp9" style="text-align: right" title="Options outstanding, Forfeited">(1,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z5J3JxazUHpc" style="text-align: right" title="Weighted average exercise price, Forfeited">0.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zedsK5PtSjih" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">(100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zciRhbAxVYZe" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.75</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zbYAz3O47z53" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">4,815,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zf834A562yJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zgYn85XUTON5" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">3,211,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNYVTTN9CfWg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

5465000

0.41

450000

0.18

1000000

0.47

100000

0.75

4815000

0.36

3211875

0.34

P3Y8M23D

Note 8: Commitments In December 2024, the Company entered into an employment agreement with Mr. Leal, which will become effective as of the effective date of the registration statement on Form S-1 in connection with the Company’s planned public offering of its shares. Pursuant to the employment agreements, Mr. Leal has agreed to serve as Chief Executive Officer and as a Director for five years from the effective date in consideration for an annualized salary of $300,000, payable in regular instalments in accordance with the usual payment practices of the Company. The employment agreement contemplates annual bonus awards based on the achievement of performance objectives and targets established annually by the Board of Directors and possible additional bonuses for services and results achieved by Mr. Leal. On July 22, 2025, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers. On August 22, 2025, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

300000

Note 9: Subsequent Events On July 14, 2026, the Company entered into Secured Promissory Note Agreements with two investors for their purchase of (i) <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK2TligvAcYc" title="Interest rate">14% secured promissory notes of the Company in the aggregate original principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zymwveGEgD2f" title="Principal amount">80,000 payable on December 31, 2026 and (ii) <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zquUAz8ac21g" title="Warrants term">5-year warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGlFdrQdKga5" title="Warrants to purchase common stock">1,131,428 shares of the Company’s common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyZRwGs4Uuh9" title="Exercise price">0.14. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260714__20260714__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsz69nh52gdj" title="Number of shares issued">3,000,000 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders.

0.14

80000

P5Y

1131428

0.14

3000000

false false false false The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date. The trading volatility was determined by calculating the volatility of the Company’s peer group. The Company does not expect to pay a dividend in the foreseeable future. The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date. The trading volatility was determined by calculating the volatility of the Company’s peer group. The Company does not expect to pay a dividend in the foreseeable future.